The increasing prevalence of bipolar disorder – The exact cause that leads to an individual developing bipolar disorder is unknown. Research studies and surveys over the years have concluded that bipolar disorder can develop in response to environmental triggers. It is believed that children are born with a vulnerability that they might develop bipolar disorder. However, they may not develop it altogether. When and how they might or might not develop the condition would significantly depend on their genetics and surrounding environment. For instance, stressful events like the death of a loved one, substance abuse, or trauma may trigger the condition. Several organizations have reported an increase in the diagnosis of bipolar disorder in young individuals. The exact reasons for such a dramatic patient count increase are unknown. It is attributed to increasing awareness about the condition and providing affordable and accessible diagnostic and supportive care to the patients. The awareness regarding the condition also aims at destigmatizing the several stereotypes associated with the disease that dampen the confidence of individuals to ask for help. The government initiatives to develop an informed and sensitive society are increasing the out-patient count of seeking help. Scientific breakthroughs or medical research have expanded the scope of medicine to cover new aspects of the conditions by defining them under several categories. The increasing ambit of medicine to cover all aspects of the conditions leads to an increase in diagnosis, thus driving the global bipolar disorder market.
Side-effects of bipolar disorder medications are concerning – Bipolar disorder medications are powerful drugs aimed at stabilizing the patient's moods. The intended target of the drugs is to regulate the emotional highs and lows of the patients. However, the drugs have multiple side effects. The side effects can be nausea, tremors, headaches, muscle fatigue, hair loss, decreased sexual interest and loss of appetite. Some severe side effects of these drugs can be kidney or liver damage. While treating one condition, the drugs lead to several other negative developments that are equally taxing on the body, both mentally and physically. Therefore, the scope and severity of the side effects of bipolar disorder medications will hamper the growth of the market.
Increase in medical research funding – Bipolar disorder is a chronic condition with many unknowns. Extensive research and surveys are performed to understand any problem to address it comprehensively with policy interventions. Similarly, governments worldwide are increasing their funding towards bipolar disorder research to understand the condition and address it comprehensively like any other health condition. The increased funding has led to several scientific breakthroughs that have paved the way for developing better drugs, therapies and other medications that improve the lives of bipolar disorder patients. The increasing prevalence of bipolar disorder presents a vast consumer market of pharmaceutical giants. They have increased their research and development expenditure to develop bipolar disorder treatments like novel drugs and medical technology to exploit the growing market.
Misdiagnosis and no diagnosis of the condition – The social stigma associated with bipolar disorder discourage several individuals from seeking medical help. The lack of awareness about mental conditions like bipolar disorder in low- and middle-income countries leaves thousands of needy patients without supportive care. The social stigma leads no thousands of cases going unreported. Furthermore, the ambiguous difference between bipolar disorder and depression leads to the bipolar disorder being misdiagnosed as depression. The misdiagnoses lead to an entirely different treatment plan which fails to address the actual condition. Therefore, low to no reporting of bipolar disorder and misdiagnosis of the conditions will impede the growth of the global market.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Drug Class
4.3.2. Market Attractiveness Analysis by Mechanism of Action
4.3.3. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. The increasing bipolar disorder population
5.3. Restraints
5.3.1. Undesirable effects of bipolar disorder drugs
5.4. Opportunities
5.4.1. Increasing research and development expenditure
5.5. Challenges
5.5.1. Patent expiry on generic drugs developed by market players
6. Global Bipolar Disorder Market Analysis and Forecast, By Drug Class
6.1. Segment Overview
6.2. Mood Stabilizers
6.3. Antipsychotic Drugs
6.4. Antianxiety Drugs
6.5. Anticonvulsants
6.6. Antidepressant Drugs
6.7. Others
7. Global Bipolar Disorder Market Analysis and Forecast, By Mechanism of Action
7.1. Segment Overview
7.2. Selective Serotonin Reuptake Inhibitors
7.3. Tricyclic Antidepressants
7.4. Benzodiazepines
7.5. Serotonin Norepinephrine Reuptake Inhibitors
7.6. Monoamine Oxidase
7.7. Beta Blockers
7.8. Others
8. Global Bipolar Disorder Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Bipolar Disorder Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in the Bipolar Disorder Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. AbbVie Inc.
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Allergen Plc
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. AstraZeneca
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Eli Lilly
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. GlaxoSmithKline
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Janssen Pharmaceuticals
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Johnson & Johnson Company
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Novartis AG
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Otsuka Holdings Co. Ltd.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Pfizer Inc.
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
2. Global Mood Stabilizers Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
3. Global Antipsychotic Drugs Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
4. Global Antianxiety Drugs Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
5. Global Anticonvulsants Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
6. Global Antidepressant Drugs Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
7. Global Others Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
8. Global Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
9. Global Selective Serotonin Reuptake Inhibitors Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
10. Global Tricyclic Antidepressants Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
11. Global Benzodiazepines Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
12. Global Serotonin Norepinephrine Reuptake Inhibitors Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
13. Global Monoamine Oxidase Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
14. Global Beta Blockers Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
15. Global Others Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
16. Global Bipolar Disorder Market, By Region, 2020-2033 (USD Billion)
17. North America Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
18. North America Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
19. U.S. Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
20. U.S. Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
21. Canada Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
22. Canada Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
23. Mexico Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
24. Mexico Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
25. Europe Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
26. Europe Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
27. Germany Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
28. Germany Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
29. France Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
30. France Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
31. U.K. Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
32. U.K. Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
33. Italy Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
34. Italy Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
35. Spain Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
36. Spain Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
37. Asia Pacific Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
38. Asia Pacific Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
39. Japan Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
40. Japan Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
41. China Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
42. China Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
43. India Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
44. India Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
45. South America Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
46. South America Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
47. Brazil Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
48. Brazil Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
49. Middle East and Africa Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
50. Middle East and Africa Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
51. UAE Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
52. UAE Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
53. South Africa Bipolar Disorder Market, By Drug Class, 2020-2033 (USD Billion)
54. South Africa Bipolar Disorder Market, By Mechanism of Action, 2020-2033 (USD Billion)
List of Figures
1. Global Bipolar Disorder Market Segmentation
2. Bipolar Disorder Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Bipolar Disorder Market Attractiveness Analysis By Drug Class
9. Global Bipolar Disorder Market Attractiveness Analysis By Mechanism of Action
10. Global Bipolar Disorder Market Attractiveness Analysis by Region
11. Global Bipolar Disorder Market: Dynamics
12. Global Bipolar Disorder Market Share By Drug Class (2023 & 2033)
13. Global Bipolar Disorder Market Share By Mechanism of Action (2023 & 2033)
14. Global Bipolar Disorder Market Share by Regions (2023 & 2033)
15. Global Bipolar Disorder Market Share by Company (2023)
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global bipolar disorder market based on below-mentioned segments:
Global Bipolar Disorder Market by Drug Class:
Global Bipolar Disorder Market by Mechanism of Action:
Global Bipolar Disorder Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date